Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: 
Comparison of the average rTmax of each ROI in patients with carotid stenosis before and after stenting
Before Stenting (n = 25) After Stenting (n = 25) P Value
AP view
    ICA-AP 0.35 ± 0.31 0.17 ± 0.22 0.002^*
    A1 0.54 ± 0.39 (n = 15) 0.49 ± 0.44 0.28
    M1 0.72 ± 0.41 0.53 ± 0.39 0.01^*
    M3 1.05 ± 0.41 1.18 ± 1.58 0.33
    IJV 6.83 ± 1.11 6.58 ± 1.35 0.38
    MCV 3.79 ± 2.04 3.75 ± 1.50 0.47
Lateral view
    ICA-LAT 0.23 ± 0.25 0.11 ± 0.15 0.01^*
    OphA 0.97 ± 0.67 0.54 ± 0.54 0.01^*
    A2 0.86 ± 0.68 (n = 15) 0.53 ± 0.48 0.01^*
    A3 1.03 ± 0.62 (n = 15) 0.84 ± 0.50 0.02^*
    M2 1.31 ± 0.59 1.07 ± 0.55 0.03^*
    FV 5.12 ± 1.4 4.84 ± 1.25 0.22
    PV 5.41 ± 0.87 4.89 ± 1.28 0.18
    OV 5.36 ± 1.41 4.88 ± 1.21 0.11
    SSS 6.28 ± 1.60 6.04 ± 2.12 0.31
    SS 6.64 ± 1.56 6.25 ± 2.10 0.40


↵* Statistically significant (p < 0.05).

	Before Stenting (n = 25)	After Stenting (n = 25)	P Value
AP view
ICA-AP	0.35 ± 0.31	0.17 ± 0.22	0.002^*
A1	0.54 ± 0.39 (n = 15)	0.49 ± 0.44	0.28
M1	0.72 ± 0.41	0.53 ± 0.39	0.01^*
M3	1.05 ± 0.41	1.18 ± 1.58	0.33
IJV	6.83 ± 1.11	6.58 ± 1.35	0.38
MCV	3.79 ± 2.04	3.75 ± 1.50	0.47
Lateral view
ICA-LAT	0.23 ± 0.25	0.11 ± 0.15	0.01^*
OphA	0.97 ± 0.67	0.54 ± 0.54	0.01^*
A2	0.86 ± 0.68 (n = 15)	0.53 ± 0.48	0.01^*
A3	1.03 ± 0.62 (n = 15)	0.84 ± 0.50	0.02^*
M2	1.31 ± 0.59	1.07 ± 0.55	0.03^*
FV	5.12 ± 1.4	4.84 ± 1.25	0.22
PV	5.41 ± 0.87	4.89 ± 1.28	0.18
OV	5.36 ± 1.41	4.88 ± 1.21	0.11
SSS	6.28 ± 1.60	6.04 ± 2.12	0.31
SS	6.64 ± 1.56	6.25 ± 2.10	0.40